MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 29, 14:23
1701.00
4.4 (0.26%)
VOLUME 3,232
LIVE
NSE
May 29, 14:23
1702.00
5 (0.29%)
VOLUME 79,585
Management Interviews on Dr Reddys Laboratories
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Business from Russia, US markets add to Dr Reddy's coffers 

6.21 pm | 25 Oct 2011 |  Source: CNBC-TV18

G V Prasad, VC & CEO, Dr Reddy's Laboratories tells CNBC-TV18 that North America, Russia and the Pharmaceuticals Services and Active Ingredients (PSAI...

JB Chem to use major sale proceeds to reward shareholders 

11.17 am | 25 Jul 2011 |  Source: CNBC-TV18

Leading global pharmaceutical company JB Chemical has sold its prescription business to Dr Reddy's for USD 35 million. In an exclusive interview with ...

Product launch, US sales to aid growth in H2FY12: DRL 

6.54 pm | 20 Jul 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, GV Prasad, vice-chairman & CEO of DRL spoke about the company's quarterly performance and future plans. ...

To improve market share, position in Germany: Dr Reddy's 

6.35 pm | 13 May 2011 |  Source: CNBC-TV18

GV Prasad, Vice Chairman and CEO, Dr Reddys Laboratories in an interview with CNBC-TV18 spoke about the quarterly numbers of the company and the road ...

Unsure of how biz will shape up in German mkt: Dr Reddy's 

4.54 pm | 25 Jan 2011 |  Source: CNBC-TV18

Speaking to CNBC-TV18 on the quarter gone by, GV Prasad, Vice Chairman & CEO, Dr Reddy Laboratories said operating expenses have increased due to one-...

What is Lupin's acquisition agenda for the future? 

4.27 pm | 22 Jan 2011 |  Source: CNBC-TV18

Kamal Sharma, Managing Director of Lupin, started four decades ago almost as a stockiest and C&F agent. Today, his company is one of India’s largest d...

Ranbaxy, Merck call off anti-infectives deal 

10.10 pm | 04 Jan 2011 |  Source: CNBC-TV18

Drug majors Ranbaxy and Merck have called off a deal that would have seen both the pharma giants join hands to research anti-infectives, reports Pharm...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.